ArticleThe Veterinary record2026
Effect of butorphanol in combination with xylazine during castration of calves: A randomised trial under field conditions.
Article in The Veterinary record, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn horses, cats and dogs, the opioid butorphanol has been proven effective in management of visceral pain and for peri- and postoperative pain relief. The aim of this study was to evaluate physiological responses and indicators of noxious stimuli when adding butorphanol to xylazine for sedation of bull calves during surgical castration.
methodsIn total, 54 bull calves were randomly assigned to a control group sedated with only xylazine and a treatment group sedated with the addition of butorphanol prior to castration. Observation of physiological responses by blinded observers from sedation and 1 hour onwards.
resultsApart from significantly more vocalisations in the treatment group prior, during and after the surgical procedure, no adverse effects of butorphanol addition were noted. Also, improved alertness and less drowsiness 1 hour after initiation of sedation were seen in the treatment group possibly associated with improved analgesia. LIMITATIONS: A longer follow-up time after sedation and additional measurements of cortisol levels would have given additional valuable information
conclusionAddition of butorphanol leads to increased vocalisation during and possibly a shortened recovery time post-sedation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.